Randomized Comparison of Xience V and Multi-Link Vision Coronary Stents in the Same Multivessel Patient With Chronic Kidney Disease (RENAL-DES) Study | Zendy

Fabrizio Tomai | Zendy; Flavio Ribichini | Zendy; Leonardo De Luca | Zendy; Alessandro Petrolini | Zendy; Anna S. Ghini | Zendy; Luca Weltert | Zendy; Carmen Spaccarotella | Zendy; Igino Proietti | Zendy; Carlo Trani | Zendy; Francesco Nudi | Zendy; Michele Pighi | Zendy; Corrado Vassanelli | Zendy

Open Access

Randomized Comparison of Xience V and Multi-Link Vision Coronary Stents in the Same Multivessel Patient With Chronic Kidney Disease (RENAL-DES) Study

Author(s) -

Fabrizio Tomai,

Flavio Ribichini,

Leonardo De Luca,

Alessandro Petrolini,

Anna S. Ghini,

Luca Weltert,

Carmen Spaccarotella,

Igino Proietti,

Carlo Trani,

Francesco Nudi,

Michele Pighi,

Corrado Vassanelli

Publication year - 2013

Publication title -

circulation

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 7.795

H-Index - 607

eISSN - 1524-4539

pISSN - 0009-7322

DOI - 10.1161/circulationaha.113.005186

Subject(s) - medicine , kidney disease , cardiology , revascularization , percutaneous coronary intervention , coronary artery disease , odds ratio , stent , confidence interval , renal function , randomized controlled trial , surgery , myocardial infarction

Percutaneous coronary interventions in patients with chronic kidney disease have shown suboptimal results. Drug-eluting stents (DES) might reduce the rate of target vessel revascularization in comparison with bare-metal stents (BMS) in patients with chronic kidney disease. However, given the multiple concomitant individual variables present in such patients, the comparison of neointimal growth after percutaneous coronary intervention is complex and difficult to assess.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research